Mariguette®

  • Season: Everbearing
  • Main characteristic/s: Very sweet flavour, excellent shelf life
  • Breeder: Marionnet SAS, France
Characteristics of Mariguette®
  • Very sweet flavoured berries with a pleasant fragrance
  • High Brix levels
  • Excellent shelf life and berry firmness
  • Attractive, glossy bright red berries
  • High fruit yields
Cropping Season
Mariguette® is an everbearing strawberry cropping from the beginning of July.

Fruit Quality
The berries are large and oblong in shape, orange-red in colour with a very shiny skin finish. The flavour has good sweetness with a high Brix index and a subtler fragrance than Mara des Bois. The shelf life and berry firmness are excellent.

Fruit Yield
Mariguette® has a high yield potential, better than Charlotte, particularly in spring production from a tray plant.

Plant Characteristics
Plants are fairly robust with cupped spoon-like leaves. Mariguette® is well adapted to substrate production using tray plants.

Plant Supply
Mariguette® (Marionnet 99) is protected under Community (EU) Plant Variety Rights (Grant No: 43040 ); Switzerland PBR (Grant No: 16.2617); Australia PBR Application No: 2016/380; Canada Grant No:5842; Morocco PBR Application No: 526/14. The propagation and sale of plants, or parts of plants, of Mariguette® without a licence is prohibited. Only Propagation Licence holders can propagate and receive propagation grade material (and not Sales or Growing-on Transformation Licence holders). Mariguette® is available from the following licensed propagators:

Propagation Licence Holders

  • Country
  • Company
  • Website
  • Telephone

Sales Licence Holders (Commercial Growers)

  • Country
  • Company
  • Website
  • Telephone

Sales Licence Holders (Amateur/Garden Market ONLY)

  • Country
  • Company
  • Website
  • Telephone
  • UK
  • D.T. Brown Seeds T/A Fothergill's Seeds Ltd
  • Visit website
  • +44 01638 751 161
  • None available

Growing-on / Transformation Licence Holders

  • Country
  • Company
  • Website
  • Telephone
Trial Results
Raised bed trials: